These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38773567)

  • 1. Field testing of user-friendly perennial malaria chemoprevention packaging in Benin, Côte d'Ivoire and Mozambique.
    Faye SLB; Lugand MM; Offianan AT; Dossou-Yovo A; Kouadio DKM; Pinto F
    Malar J; 2024 May; 23(1):157. PubMed ID: 38773567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introducing post-discharge malaria chemoprevention (PMC) for management of severe anemia in Malawian children: a qualitative study of community health workers' perceptions and motivation.
    Nkosi-Gondwe T; Robberstad B; Blomberg B; Phiri KS; Lange S
    BMC Health Serv Res; 2018 Dec; 18(1):984. PubMed ID: 30567567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coverage of intermittent prevention treatment with sulphadoxine-pyrimethamine among pregnant women and congenital malaria in Côte d'Ivoire.
    Vanga-Bosson HA; Coffie PA; Kanhon S; Sloan C; Kouakou F; Eholie SP; Kone M; Dabis F; Menan H; Ekouevi DK
    Malar J; 2011 Apr; 10():105. PubMed ID: 21529344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coverage and efficacy of intermittent preventive treatment with sulphadoxine pyrimethamine against malaria in pregnancy in Côte d'Ivoire five years after its implementation.
    Toure OA; Kone PL; Coulibaly MA; Ako BA; Gbessi EA; Coulibaly B; N' Guessan LT; Koffi D; Beourou S; Soumahoro A; Bassinka I; Nogbou M; Swa T; Gba B; Esmel B; Bokossa EM
    Parasit Vectors; 2014 Nov; 7():495. PubMed ID: 25410760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceptability of coupling intermittent preventive treatment in infants with the expanded programme on immunization in three francophone countries in Africa.
    de Sousa A; Rabarijaona LP; Ndiaye JL; Sow D; Ndyiae M; Hassan J; Lambo N; Adovohekpe P; Guidetti F; Recht J; Affo A
    Trop Med Int Health; 2012 Mar; 17(3):308-15. PubMed ID: 22128893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Limits of the efficacy of chloroquine and sulfadoxine-pyrimethamine in Northern Abidjan (Cote d'Ivoire): Combined in vivo and in vitro studies].
    Djaman J; Abouanou S; Basco L; Koné M
    Sante; 2004; 14(4):205-9. PubMed ID: 15745869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study.
    ACCESS-SMC Partnership
    Lancet; 2020 Dec; 396(10265):1829-1840. PubMed ID: 33278936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-discharge malaria chemoprevention (PMC) in Malawi: caregivers` acceptance and preferences with regard to delivery methods.
    Svege S; Kaunda B; Robberstad B; Nkosi-Gondwe T; Phiri KS; Lange S
    BMC Health Serv Res; 2018 Jul; 18(1):544. PubMed ID: 29996833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How sulfadoxine-pyrimethamine (SP) was perceived in some rural communities after phasing out chloroquine (CQ) as a first-line drug for uncomplicated malaria in Tanzania: lessons to learn towards moving from monotherapy to fixed combination therapy.
    Nsimba SE
    J Ethnobiol Ethnomed; 2006 Jan; 2():5. PubMed ID: 16403225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing the uptake of Intermittent Preventive Treatment of malaria in pregnancy using Sulfadoxine-Pyrimethamine (IPTp-SP) through seasonal malaria chemoprevention channel delivery: protocol of a multicenter cluster randomized implementation trial in Mali and Burkina Faso.
    Koita K; Bognini JD; Agboraw E; Dembélé M; Yabré S; Bihoun B; Coulibaly O; Niangaly H; N'Takpé JB; Lesosky M; Scaramuzzi D; Worrall E; Hill J; Briand V; Tinto H; Kayentao K
    BMC Public Health; 2024 Jan; 24(1):43. PubMed ID: 38166711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vivo evaluation of sulfadoxine-pyrimethamine efficacy during uncomplicated falciparum malaria in children of Yopougon (Abidjan, Côte d'Ivoire)].
    Djaman JA; Kauffy PC; Yavo W; Basco LK; Kone M
    Bull Soc Pathol Exot; 2004 Aug; 97(3):180-2. PubMed ID: 15462199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of iron-fortified complementary food and intermittent preventive treatment of malaria on anaemia in 12- to 36-month-old children: a cluster-randomised controlled trial.
    Glinz D; Hurrell RF; Ouattara M; Zimmermann MB; Brittenham GM; Adiossan LG; Righetti AA; Seifert B; Diakité VG; Utzinger J; N'Goran EK; Wegmüller R
    Malar J; 2015 Sep; 14():347. PubMed ID: 26377199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the knowledge of intermittent preventive treatment during pregnancy (IPTp) with sulfadoxine-pyrimethamine in Ivory Coast].
    Yavo JC; Amari ASG; Assi SB; Assemian A; Kouamé R; Balayssac E; Kamagaté M
    Therapie; 2019 Sep; 74(4):487-494. PubMed ID: 30904318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of post-discharge malaria chemoprevention (PDMC) in Benin, Kenya, Malawi, and Uganda: stakeholder engagement meeting report.
    Hill J;
    Malar J; 2024 Mar; 23(1):89. PubMed ID: 38539181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Field evaluation of the intermittent preventive treatment of malaria during pregnancy (IPTp) in Benin: evolution of the coverage rate since its implementation.
    d'Almeida TC; Agboton-Zoumenou MA; Garcia A; Massougbodji A; Briand V; Imorou Y; Cottrell G
    Parasit Vectors; 2011 Jun; 4():108. PubMed ID: 21679439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence of community caretakers of children to pre-packaged antimalarial medicines (HOMAPAK) among internally displaced people in Gulu district, Uganda.
    Kolaczinski JH; Ojok N; Opwonya J; Meek S; Collins A
    Malar J; 2006 May; 5():40. PubMed ID: 16700903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population Pharmacokinetic Properties of Sulfadoxine and Pyrimethamine: a Pooled Analysis To Inform Optimal Dosing in African Children with Uncomplicated Malaria.
    de Kock M; Tarning J; Workman L; Allen EN; Tekete MM; Djimde AA; Bell DJ; Ward SA; Barnes KI; Denti P
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29463542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of a fixed-dose combination of artesunate and amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in real-life conditions of use in Côte d'Ivoire.
    Assi SB; Aba YT; Yavo JC; Nguessan AF; Tchiekoi NB; San KM; Bissagnéné E; Duparc S; Lameyre V; Tanoh MA
    Malar J; 2017 Jan; 16(1):8. PubMed ID: 28049523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intermittent preventive treatment for malaria during infancy on serological responses to measles and other vaccines used in the Expanded Programme on Immunization: results from five randomised controlled trials.
    Crawley J; Sismanidis C; Goodman T; Milligan P;
    Lancet; 2012 Sep; 380(9846):1001-10. PubMed ID: 22850358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.